SCHEMBL1750571

SCHEMBL1750571

COC(=O)c1nc2n(c(=O)c1OC(=O)c1ccccc1)CCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.45
ALDH1A1 P00352 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 2/20 0.45
USP2 O75604 2/20 0.45
CYP1A2 P05177 1/20 0.45
BCHE P06276 1/20 0.45
CFTR P13569 1/20 0.45
ALOX15 P16050 1/20 0.45
ACHE P22303 1/20 0.45
HKDC1 Q2TB90 1/20 0.45
GOPC Q9HD26 1/20 0.45
HTT P42858 3/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 3/20 0.43
RXFP1 Q9HBX9 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1749658 0.97 TP53 (0.47) APOBEC3AAPOBEC3GL3MBTL1ALDH1A1TDP1
SCHEMBL1749341 0.96 TP53 (0.48) APOBEC3AAPOBEC3GL3MBTL1ALDH1A1TP53
SCHEMBL31394514 0.82 LMNA (0.47) L3MBTL1ALDH1A1TDP1HSD17B10KDM4E
SCHEMBL1749342 0.80 HRH1 (0.36) ALDH1A1KDM4ECYP1A2MAPTSMN1; SMN2
SCHEMBL1750917 0.79 TP53 (0.48) L3MBTL1ALDH1A1TDP1HSD17B10KDM4E
SCHEMBL1750536 0.79 KMT2A (0.36) ALDH1A1KDM4ECYP1A2TP53RAB9A
SCHEMBL14303989 0.78 KMT2A (0.36) APOBEC3AAPOBEC3GALDH1A1KDM4EHTT
SCHEMBL1750172 0.78 TSHR (0.38) ALDH1A1HSD17B10KDM4ECYP1A2MAPK1
SCHEMBL1750234 0.75 MAPT (0.45) L3MBTL1ALDH1A1TDP1HSD17B10KDM4E
SCHEMBL12222752 0.73 ALDH1A1 (0.39) ALDH1A1HSD17B10KDM4EALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968553-B2 e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2011-06-28 US disclosed
EP-1578748-B1 TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2010-09-15 EP disclosed
US-7414045-B2 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-08-19 US disclosed
US-20080176869-A1 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors MSD ITALIA S.R.L. (IT) 2008-07-24 US disclosed
US-20060046985-A1 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors MSD ITALIA S.R.L. (IT) 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060046985-A1 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors TYMS, TYMP, HPRT1 APOBEC3A 235/4885APOBEC3G 387/4885L3MBTL1 1333/4885
US-20080176869-A1 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors TYMS, TYMP, DPYD APOBEC3A 191/4885APOBEC3G 369/4885L3MBTL1 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.